135 related articles for article (PubMed ID: 28778431)
41. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
42. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H
Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502
[TBL] [Abstract][Full Text] [Related]
43. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
Balnyte R; Rastenyte D; Vaitkus A; Mickeviciene D; Skrodeniene E; Vitkauskiene A; Uloziene I
BMC Neurol; 2013 Jul; 13():77. PubMed ID: 23837503
[TBL] [Abstract][Full Text] [Related]
44. Variants of Interleukin-7/Interleukin-7 Receptor Alpha are Associated with Both Neuromyelitis Optica and Multiple Sclerosis Among Chinese Han Population in Southeastern China.
Zhuang JC; Wu L; Qian MZ; Cai PP; Liu QB; Zhao GX; Li ZX; Wu ZY
Chin Med J (Engl); 2015 Nov; 128(22):3062-8. PubMed ID: 26608987
[TBL] [Abstract][Full Text] [Related]
45. HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Núñez C; Cénit MC; Alvarez-Lafuente R; Río J; Fernández-Arquero M; Arroyo R; Montalbán X; Fernández O; Oliver-Martos B; Leyva L; Comabella M; Urcelay E
J Med Genet; 2014 Jun; 51(6):395-400. PubMed ID: 24748646
[TBL] [Abstract][Full Text] [Related]
46. HLA-DQ A1, -DQB1 and -DRB1 gene polymorphism--in Malay type 1 diabetes mellitus patients and their use for risk prediction.
Rohana AG; Loh KC; Tin SK; Soh CH; Nazaimoon WM; Fong KY; Azmi KN; Khalid BA
Med J Malaysia; 2011 Jun; 66(2):133-7. PubMed ID: 22106694
[TBL] [Abstract][Full Text] [Related]
47. HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Matiello M; Schaefer-Klein J; Brum DG; Atkinson EJ; Kantarci OH; Weinshenker BG;
Mult Scler; 2010 Aug; 16(8):981-4. PubMed ID: 20591987
[TBL] [Abstract][Full Text] [Related]
48. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
49. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
50. The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females.
Paradela ER; Alves-Leon SV; Figueiredo AL; Pereira VC; Malfetano F; Mansur LF; Scherpenhuijzen S; Agostinho LA; Rocha CF; Rueda-Lopes F; Gasparetto E; Paiva CL
Arq Neuropsiquiatr; 2015 Apr; 73(4):283-8. PubMed ID: 25992516
[TBL] [Abstract][Full Text] [Related]
51. HLA-DRB1, -DQA1 and -DQB1 genotyping of 180 Czech individuals from the Czech Republic pop 3.
Zajacova M; Kotrbova-Kozak A; Cerna M
Hum Immunol; 2016 Apr; 77(4):365-6. PubMed ID: 26867812
[TBL] [Abstract][Full Text] [Related]
52. Association of class I and II HLA alleles and haplotypes with susceptibility to vitiligo: a study of patients with vitiligo from southeast Brazil.
Ramire LD; Marcos EV; Godoy DA; de Souza-Santana FC
Int J Dermatol; 2016 Jun; 55(6):e347-55. PubMed ID: 26769539
[TBL] [Abstract][Full Text] [Related]
53. A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
Arellano B; Hussain R; Miller-Little WA; Herndon E; Lambracht-Washington D; Eagar TN; Lewis R; Healey D; Vernino S; Greenberg BM; Stüve O
PLoS One; 2016; 11(4):e0152720. PubMed ID: 27054574
[TBL] [Abstract][Full Text] [Related]
54. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
55. Interleukin 17 gene polymorphism is associated with anti-aquaporin 4 antibody-positive neuromyelitis optica in the Southern Han Chinese--a case control study.
Wang H; Zhong X; Wang K; Qiu W; Li J; Dai Y; Hu X
J Neurol Sci; 2012 Mar; 314(1-2):26-8. PubMed ID: 22118860
[TBL] [Abstract][Full Text] [Related]
56. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
Yang Y; Huang DH; Wu L; Wu WP
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
[TBL] [Abstract][Full Text] [Related]
57. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
58. Neuromyelitis optica and multiple sclerosis in sisters.
Cabrera-Gómez JA; Ramón-Pérez L; Saiz A; Llerena-Fernández P; Fernández-Fernández L; Ercilla G; Grass-Fernández D; Robinson-Agramonte MA; Romero-García K; Macías-Betancourt R; Galvizu-Sánchez R; Otero-Motolá C; Sojo-Gómez M; Aguilar-Arias C; Rodríguez-Cordero M; González-Quevedo A
Mult Scler; 2009 Feb; 15(2):269-71. PubMed ID: 18922832
[TBL] [Abstract][Full Text] [Related]
59. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
[TBL] [Abstract][Full Text] [Related]
60. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
